PTPN22 and metastatic neoplasm: Due to the inherent advantages in the recognition of tumor cells, tumor lymphatics and tumor-associated macrophages, different LyP-1-based imaging agents have been applied in metastatic tumors in lymph nodes (LNs) and lung.